Cargando…
Long-term post-marketing surveillance of mizoribine for the treatment of lupus nephritis: Safety and efficacy during a 3-year follow-up
OBJECTIVE: To determine the safety and efficacy of long-term use of mizoribine by undertaking a 3-year post-marketing surveillance study. METHODS: Subjects were all lupus nephritis patients newly treated with mizoribine between 1 October 2003 and 30 September 2005 at contracted study sites. RESULTS:...
Autores principales: | Yagi, Nobuyuki, Okada, Kenya, Sudo, Yohei, Itoh, Hiromichi, Yoshida, Hisao, Kuroda, Tatsuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607187/ https://www.ncbi.nlm.nih.gov/pubmed/26770729 http://dx.doi.org/10.1177/2050312114533960 |
Ejemplares similares
-
Comparative efficacy and safety of mizoribine and mycophenolate
mofetil for treating systemic lupus erythematosus: a retrospective cohort
study
por: Ayano, Masahiro, et al.
Publicado: (2022) -
Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome
por: Saito, Takao, et al.
Publicado: (2016) -
Mizoribine: A New Approach in the Treatment of Renal Disease
por: Kawasaki, Yukihiko
Publicado: (2009) -
Novel Autoantigens Associated with Lupus Nephritis
por: Onishi, Sachiko, et al.
Publicado: (2015) -
IgG4-Related Tubulointerstitial Nephritis Associated with Membranous Nephropathy in Two Patients: Remission after Administering a Combination of Steroid and Mizoribine
por: Miyata, Kana N., et al.
Publicado: (2014)